Would you give immunotherapy to patient with metastatic NSCLC who had liver transplant for hepatocellular carcinoma and now is progressing on chemotherapy?

Would you give immunotherapy to patient with metastatic NSCLC who had liver transplant for hepatocellular carcinoma and now is progressing on chemotherapy?

• No. Immunotherapy is contra-indicated in an organ transplant patient
• Yes- as long as transplant team permits
• Yes but only after expanded molecular testing and PD-L1 testing
• Yes but only after progression on second line chemotherapy
• Yes but only if options 2, 3 and 4 are all met
• Other